Social Media Withdrawal in Pregnancy: Effects on Maternal Mental Health and Misinformation
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Massachusetts General Hospital
- Study ID
- NCT07812506
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Pregnancy
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Brick device — DEVICEA hardware-based device that restricts access to user-selected social media applications by requiring physical interaction with the device to unlock them. Participants in the intervention arm will use the device continuously to block access to selected social media apps during a 2-week intervention period, following a 2-week baseline monitoring period. The device is not an FDA-regulated medical device and functions as a consumer hardware tool. Participants may voluntarily reverse the intervention (unlock the device) at any point during the study.
Study Details
The goal of this clinical trial is to learn if restricting social media use with a hardware device can improve mental health and well-being during pregnancy. It will also learn about the feasibility and acceptability of this approach. The main questions it aims to answer are: * Does restricting social media use lower the amount of time participants spend on social media? * Does restricting social media use improve depression, anxiety, well-being, loneliness, sleep, and physical activity? Researchers will compare participants who use a device (Brick™) that restricts social media apps to participants receiving usual care to see if the device improves social media use and mental health outcomes. Participants will: * Complete surveys about mood, sleep, and social media use, and wear/carry a smartphone app that tracks activity and sleep * Use the Brick device to restrict social media apps for 2 weeks, or continue their usual phone use * Complete follow-up surveys at the end of the 4-week study
Key Dates
- First listed
- Sep 10, 2026
- Start date
- Oct 1, 2026
- Status verified
- Sep 2026
- Primary completion
- Oct 1, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 70 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: InterventionParticipants randomized to this arm will complete a 2-week baseline monitoring period followed by a 2-week intervention period. During the intervention period, participants will receive the Brick™ device, a hardware-based tool that restricts access to user-selected social media applications by requiring physical interaction with the device to unlock them. Participants will be instructed on device use and asked to use it continuously to block access to their selected social media apps for the duration of the 2-week intervention period. Participants may voluntarily reverse the intervention at any point during the study.
- No Intervention: Usual CareParticipants randomized to this arm will complete a 2-week baseline monitoring period followed by a 2-week period of continued usual smartphone and social media behavior, without any restriction on app access. No intervention device or procedure is administered during this period. As additional compensation, participants in this arm will receive a Brick™ device following completion of all study procedures.
Primary Outcome Measure
Percent reduction in social media screen time [ Time Frame: 2-week intervention period ]
Central Contacts
- Lydia Shook, MD(617) 724-0287
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | - |
Find similar trials in Boston, MA
Related Studies
- Advanced Fetal Imaging - Phase IIRecruiting · Boston Children's Hospital · Boston, Massachusetts
- Gastric Emptying of Water and Sports Drink in LaborRecruiting · Beth Israel Deaconess Medical Center · Boston, Massachusetts
- Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive YearsRecruiting · Emory University · Boston, Massachusetts
- Study of Ultomiris® (Ravulizumab) Safety in PregnancyRecruiting · Alexion Pharmaceuticals, Inc. · Boston, Massachusetts